Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,171 recruiting studies in this area right now.
By phase
- Not applicable9,517
- Phase 24,403
- Phase 12,662
- Phase 1/Phase 21,653
- Phase 31,392
- Phase 2/Phase 3284
- Phase 4260
Top conditions
- Breast Cancer1,197
- Prostate Cancer645
- Cancer634
- Colorectal Cancer481
- Lung Cancer417
- Ovarian Cancer337
- Multiple Myeloma329
- Pancreatic Cancer290
- Gastric Cancer283
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor246
- Advanced Solid Tumor234
- Head and Neck Cancer225
- Cervical Cancer224
- Endometrial Cancer209
- Advanced Solid Tumors202
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University302
- National Cancer Institute (NCI)292
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University273
- Mayo Clinic238
- City of Hope Medical Center142
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences141
- AstraZeneca133
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,410
- Texas635
- Arizona509
- Florida435
- Alabama427
- New York404
- Massachusetts340
- Maryland330
- New Jersey271
- Pennsylvania234
Recruiting studies20,171 total
- NCT06764134Recruiting
Testing a new stapler to prevent pancreatic leaks after surgery
This trial tests a new type of stapler (AEON) used during surgery to remove the left part of the pancreas. The goal is to see if it helps reduce the risk of a leak from the pancreas after surgery.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06643754RecruitingPhase 1/Phase 2
Study of a new drug (SHR-3276) for advanced cancers
This trial tests a new drug called SHR-3276 for people with advanced cancers that haven't responded to standard treatments. It aims to see if the drug is safe and works against tumors.
Chongqing, Chongqing MunicipalityAges 18–70 - NCT06762782RecruitingPhase 2
Lenvatinib after liver cancer surgery to prevent recurrence
This trial tests whether taking lenvatinib after liver cancer surgery can lower the chance of the cancer coming back. It is for people who have a high risk of recurrence and have recently had their liver tumor completely removed.
Nanjing, JiangsuAges 18–80 - NCT06764524Recruiting
Hairy Cell Leukemia: studying tiny cell particles to improve care
This study looks at tiny particles called extracellular vesicles in the blood of people with Hairy Cell Leukemia. Researchers want to understand if these particles can help improve how the disease is managed and followed.
BolognaAges 18 years+ - NCT06764602Recruiting
Kidney health in kids with tuberous sclerosis
This study looks back at medical records to see how many children with tuberous sclerosis complex (TSC) have kidney problems. It may help doctors understand how common kidney issues are in kids with TSC.
BolognaAges Up to 17 years - NCT06762977Recruiting
Study on her2-positive early-stage breast cancer treatment
This study looks at how well a new test can help manage her2-positive early-stage breast cancer. It includes patients who have had treatment before or after surgery with trastuzumab and possibly pertuzumab.
BrindisiAges 18 years+ - NCT07506902Recruiting
Daily adjusted radiation for head and neck cancer
This trial tests a newer, more precise way of giving daily radiation for head and neck cancer. The treatment plan is adjusted each day to better target the tumor and protect healthy tissue.
CopenhagenAges 18 years+ - NCT07498907RecruitingPhase 3
Disitamab vedotin plus radiation for high-risk bladder cancer in kidney tube
This trial tests a targeted drug called disitamab vedotin combined with radiation after surgery for a rare type of bladder cancer in the upper urinary tract. It may be an option for people who cannot take standard chemotherapy because of kidney problems, hearing loss, or other health issues.
BeijingAges 18 years+ - NCT07502885Recruiting
Study of walking in children with bone or soft tissue tumors
This study looks at how children with certain bone or soft tissue tumors walk after orthopedic surgery. It aims to understand and improve their movement and recovery.
Memphis, TennesseeAges 5–20 - NCT07503496Recruiting
Biobran supplement for breast cancer chemo support
This trial tests if a supplement called Biobran (made from rice bran) can help support people with breast cancer who are receiving chemotherapy. It may reduce side effects or improve treatment tolerance.
TaichungAges 20–65 - NCT07501650RecruitingPhase 1
Pembrolizumab plus ultrasound bubbles for head and neck cancer
This trial combines the immunotherapy drug pembrolizumab (Keytruda) with a special ultrasound technique that uses tiny bubbles to make the treatment work better. It is for people with HPV-negative head and neck cancer that has come back or spread to other parts of the body.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07503730RecruitingPhase 3
Early use of realgar-indigo naturalis formula plus ATRA for APL patients
This trial tests whether giving a combination of two oral medicines—realgar-indigo naturalis formula (RIF) and all-trans retinoic acid (ATRA)—early in treatment can help people with acute promyelocytic leukemia (APL), a specific type of blood cancer. The goal is to see if this approach works better than current standard care.
Xi'an, ShaanxiAges 18–80 - NCT07503847Enrolling by invitation
Colorectal Cancer Screening for Ages 40-49 with Family History
This trial helps people aged 40-49 who have a parent, sibling, or child with colorectal cancer decide on the best way to get screened. It aims to find the most effective screening method for those at higher risk.
TaipeiAges 40–49 - NCT07499271RecruitingPhase 2
Targeted therapy for newly diagnosed DLBCL with TP53 mutation
This trial tests a targeted therapy designed to match the specific genetic subtype of DLBCL that has a TP53 mutation. It may offer a more effective treatment option for people whose cancer has this genetic change.
Suzhou, JiangsuAges 18–70 - NCT07504835Recruiting
Exercise program for older men with prostate cancer
This study tests whether a special exercise program done with other men (via video calls) can help older men with prostate cancer feel less lonely. You'd be placed in one of three groups and attend regular exercise sessions from home.
Portland, OregonAges 65 years+ - NCT07505173RecruitingPhase 2
Targeted radiation plus osimertinib for brain metastases from EGFR-mutant lung cancer
This trial tests adding a brain-sparing radiation technique to the targeted therapy drug osimertinib for people with EGFR-mutant lung adenocarcinoma that has spread to the brain and is causing symptoms. The goal is to see if this combination can better control the brain tumors while protecting the hippocampus, a key memory area.
TianjinAges 18–75 - NCT07506005Recruiting
Stapler placement study for colorectal surgery
This trial tests if the placement of the stapler spike during colorectal surgery affects bleeding where the bowel is joined. It may help guide safer stapling techniques.
LinzAges Any age - NCT07506057RecruitingPhase 2
Trastuzumab, serplulimab, and chemo for advanced bile duct or bladder cancer
This trial tests a combination of trastuzumab (a HER2-targeted drug), serplulimab (an immunotherapy), and chemotherapy for people with advanced bile duct or bladder cancer that is HER2-positive and has not responded to prior treatments. The goal is to see if this mix can shrink tumors or slow the disease.
Shenyang, LiaoningAges 18–85 - NCT07500441Recruiting
Gene test after stem cell transplant for AML
This trial uses a very sensitive blood test (digital PCR) to look for tiny amounts of leftover leukemia after a stem cell transplant, focusing on certain gene changes that are not the common fusion genes.
Beijing, Beijing MunicipalityAges Any age - NCT07504471RecruitingPhase 2
Bicarbonate plus chemo and immunotherapy for pancreatic cancer liver spread
This trial tests adding sodium bicarbonate to a chemotherapy plus immunotherapy regimen for pancreatic cancer that has spread to the liver. The goal is to see if this combination helps shrink tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07505186RecruitingPhase 2
Immunotherapy and chemotherapy before surgery for esophageal cancer
This trial tests a combination of an immunotherapy drug (camrelizumab), chemotherapy, and another targeted drug (ivarmacitinib) before surgery for esophageal cancer. The goal is to see if this treatment can shrink the tumor before it is removed, potentially improving outcomes.
Hangzhou, ChinaAges 18–75 - NCT07501026RecruitingPhase 2
Testing a new radiation method before sarcoma surgery
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
Hangzhou, ZhejiangAges 18–75 - NCT07503756RecruitingPhase 2
JS212 Combination for Untreated Metastatic Colorectal Cancer
This trial tests a new drug called JS212 in combination with other medicines for people with metastatic colorectal cancer that has not been treated before. It focuses on patients whose tumors are MSS or pMMR and aims to see if these combinations are safe and effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07503379RecruitingPhase 2
Darolutamide, hormone therapy and low-dose docetaxel for metastatic prostate cancer
This trial tests a combination of two drugs (darolutamide plus hormone therapy) along with a low dose of chemotherapy (docetaxel) for men whose prostate cancer has spread to other parts of the body. It aims to see if this combined approach is safe and effective.
Guangzhou, GuangdongAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,171 recruiting oncology studies from the U.S. registry right now, out of 30,126 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.